evodiamine has been researched along with Angiogenesis, Pathologic in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Chen, DL; Hu, L; Huang, SY; Jiang, R; Li, DY; Li, GL; Li, J; Li, LS; Li, XP; Ran, JH; Wang, YP; Zeng, D; Zhao, S; Zhou, P | 1 |
Liu, Q; Liu, Y; Luo, F; Shi, L; Yang, F; Zhang, F; Zou, M | 1 |
Hu, C; Jiang, J | 1 |
Chen, E; Lee, CC; Lin, LC; Lin, S; Shyu, KG; Tsai, SC; Wang, BW | 1 |
1 review(s) available for evodiamine and Angiogenesis, Pathologic
Article | Year |
---|---|
Evodiamine: a novel anti-cancer alkaloid from Evodia rutaecarpa.
Topics: Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Evodia; Humans; Medicine, Chinese Traditional; Neoplasms; Neovascularization, Pathologic; Plant Extracts; Quinazolines | 2009 |
3 other study(ies) available for evodiamine and Angiogenesis, Pathologic
Article | Year |
---|---|
Evodiamine inhibits vasculogenic mimicry in HCT116 cells by suppressing hypoxia-inducible factor 1-alpha-mediated angiogenesis.
Topics: Animals; Antigens, CD; Cadherins; Cell Movement; Cell Survival; Epithelial-Mesenchymal Transition; Female; HCT116 Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice, Inbred BALB C; Neovascularization, Pathologic; Quinazolines; Vascular Endothelial Growth Factor A; Wound Healing | 2021 |
Evodiamine exerts anti-tumor effects against hepatocellular carcinoma through inhibiting β-catenin-mediated angiogenesis.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; beta Catenin; Blotting, Western; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Cell Movement; Cell Survival; Evodia; Hep G2 Cells; Humans; Immunohistochemistry; Liver Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Phytotherapy; Plant Extracts; Quinazolines; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2016 |
Evodiamine inhibits in vitro angiogenesis: Implication for antitumorgenicity.
Topics: Angiogenesis Inhibitors; Capillaries; Cell Differentiation; Cell Line, Tumor; Cell Survival; Culture Media, Conditioned; Endothelial Cells; Endothelium, Vascular; Humans; Neovascularization, Pathologic; Plant Extracts; Quinazolines | 2006 |